Organization,Organization Description,Country,Organization Employee Count,Funding Total Value USD,Funding Total Currency,Last Funding Type,Categories,Organization Name,Founders,Investors
BridgeBio,BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.,United States,251-500,"$4,349,200,000",USD,post_ipo_debt,"Biotechnology, Health Care, Life Science, Medical, Pharmaceutical",BridgeBio,"Charles Homcy, Frank McCormick, Neil Kumar","Blue Owl, Sequoia Capital, Perceptive Advisors, Viking Global Investors, Kohlberg Kravis Roberts"
Healthpeak Properties,Healthpeak Properties is an investment trust for healthcare properties.,United States,101-250,"$4,250,000,000",USD,post_ipo_debt,"Health Care, Real Estate",Healthpeak Properties,,
Vaxcyte,Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.,United States,251-500,"$3,847,040,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care",Vaxcyte,"Ash Khanna, Grant E. Pickering, Jeff Fairman","RA Capital Management, TPG Growth, Longitude Capital, Frazier Healthcare Partners, Medicxi"
Altos Labs,"Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.",United States,251-500,"$3,000,000,000",USD,series_a,"Biopharma, Biotechnology, Health Care, Health Diagnostics, Medical",Altos Labs,"Hal Barron, Hans Bishop, Rick Klausner",ARCH Venture Partners
Roivant Sciences,Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.,United States,251-500,"$2,473,000,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Pharmaceutical, Product Research",Roivant Sciences,Vivek Ramaswamy,"Palantir Technologies, Founders Fund, RTW Investments, SoftBank Vision Fund, Patient Square Capital"
Amicus Therapeutics,Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.,United States,251-500,"$2,430,652,943",USD,post_ipo_debt,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Amicus Therapeutics,John Crowley,"New Enterprise Associates, MidCap Financial, Blackstone Life Sciences, Frazier Healthcare Partners, Blackstone Credit"
Omega Healthcare Investors,Omega Healthcare Investors support the goals of skilled nursing and assisted living facility operators with financing and capital.,United States,51-100,"$1,700,000,000",USD,post_ipo_debt,"Building Material, Financial Services, Health Care, Real Estate",Omega Healthcare Investors,,
Intarcia Therapeutics,Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.,United States,251-500,"$1,683,530,937",USD,series_unknown,"Biotechnology, Health Care, Health Diagnostics, Medical Device, Personal Health",Intarcia Therapeutics,,"New Enterprise Associates, Bill & Melinda Gates Foundation, Venrock, RA Capital Management, MidCap Financial"
Harmony Biosciences,Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.,United States,251-500,"$1,683,000,000",USD,post_ipo_secondary,"Biopharma, Biotechnology, Health Care",Harmony Biosciences,Jeff Aronin,"Valor Equity Partners, OrbiMed, Vivo Capital, Blackstone Life Sciences, Novo Holdings"
Revance Therapeutics,Revance is a biotechnology company focusing on aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.,United States,101-250,"$1,679,526,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Revance Therapeutics,"Dan Browne, Jacob Waugh, Jeffery Bedard","Vivo Capital, Essex Woodlands Healthcare Partners, Novaquest Capital Management, Horizon Technology Finance, Athyrium Capital Management LP"
Crinetics Pharmaceuticals,Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.,United States,251-500,"$1,646,000,012",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Crinetics Pharmaceuticals,"Scott Struthers, Stephen F. Betz, Yun-Fei Zhu","OrbiMed, RA Capital Management, Vivo Capital, Versant Ventures, 5AM Ventures"
American Healthcare REIT,American Healthcare REIT provides and offers financial support and assistance on buildings.,United States,101-250,"$1,559,770,000",USD,post_ipo_equity,"Asset Management, Fitness, Health Care, Real Estate, Real Estate Investment",American Healthcare REIT,Jeff Hanson,"Bank of America, KeyBank, Citizens Bank"
Avidity Biosciences,Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.,United States,251-500,"$1,553,167,850",USD,post_ipo_equity,"Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics",Avidity Biosciences,"Frank McCormick, Mark E. Davis, P. Kent Hawryluk, Troy Wilson","Wellington Management, Eli Lilly, RA Capital Management, Cormorant Asset Management, RTW Investments"
Celldex Therapeutics,Celldex is a clinical stage company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases.,United States,101-250,"$1,536,000,000",USD,post_ipo_equity,"Biotechnology, Health Care, Oncology, Pharmaceutical",Celldex Therapeutics,"Anthony S. Marucci, Tibor Keler",
Zogenix,Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.,United States,101-250,"$1,520,577,656",USD,post_ipo_debt,"Biotechnology, Health Care, Pharmaceutical",Zogenix,"Jonathan M. Rigby, Roger Hawley","Abingworth, Silicon Valley Bank, Domain Associates, Clarus Ventures, Scale Venture Partners"
Halozyme Therapeutics,"Halozyme Therapeutics develops extracellular matrix targeting products for the insulin, cancer, dermatology and drug delivery markets.",United States,251-500,"$1,445,000,000",USD,post_ipo_debt,"Biotechnology, Marketing, Medical",Halozyme Therapeutics,Gregory Frost,"argenx, Athyrium Capital Management LP, Silicon Valley Bank, Oxford Finance LLC, Pharmakon Advisors"
Fate Therapeutics,Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.,United States,101-250,"$1,348,828,348",USD,grant,"Biotechnology, Health Care, Therapeutics",Fate Therapeutics,"Alex Rives, David Scadden, Leonard Zon, Michael Rudnicki, Phillip Beachy, Randall Moon, Rudolf Jaenisch, Sheng Ding","Venrock, OrbiMed, ARCH Venture Partners, Polaris Partners, Adage Capital Management"
Neuralink,Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.,United States,251-500,"$1,336,241,676",USD,series_e,"Biotechnology, Medical, Neuroscience, Robotics",Neuralink,"Dongjin Seo, Elon Musk, Max Hodak","Valor Equity Partners, Sequoia Capital, Founders Fund, Lightspeed Venture Partners, Craft Ventures"
Arcus Biosciences,"Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.",United States,101-250,"$1,267,050,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Clinical Trials, Health Care, Medical, Pharmaceutical, Therapeutics",Arcus Biosciences,"Juan Jaen, Terry Rosen","Wellington Management, Novartis, Hillhouse Investment, EcoR1 Capital, Gilead Sciences"
Coherus Biosciences,"Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.",United States,251-500,"$1,264,607,132",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Oncology, Therapeutics",Coherus Biosciences,"Dennis M. Lanfear, Stephen C. Glover","Venrock, RA Capital Management, Vivo Capital, F-Prime Capital, Kohlberg Kravis Roberts"
Kura Oncology,"Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.",United States,101-250,"$1,241,425,500",USD,post_ipo_equity,"Biopharma, Biotechnology, Genetics, Health Care, Medical, Oncology, Precision Medicine",Kura Oncology,"Antonio Gualberto, Pingda Ren, Troy Wilson, Yi Liu","Deerfield Management, ARCH Venture Partners, Fidelity, OUP (Osage University Partners), EcoR1 Capital"
Turning Point Therapeutics,Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.,United States,251-500,"$1,180,709,731",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Precision Medicine, Therapeutics",Turning Point Therapeutics,"J. Jean Cui, Y. Peter Li","Cormorant Asset Management, OrbiMed, Foresite Capital, Lilly Asia Ventures, Nextech Invest"
iRhythm Technologies,iRhythm Technologies provides diagnostic monitoring solutions that facilitate the early diagnosis and treatment of cardiac arrhythmia.,United States,101-250,"$1,176,771,781",USD,post_ipo_debt,"Health Care, Health Diagnostics, Medical Device, mHealth, Wearables",iRhythm Technologies,Uday Kumar,"Norwest Venture Partners, Novo Holdings, Stanford University, Kaiser Permanente Ventures, New Leaf Venture Partners"
Eikon Therapeutics,Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.,United States,251-500,"$1,122,700,000",USD,series_d,"Biotechnology, Health Care, Life Science, Medical",Eikon Therapeutics,"Eric Betzig, Luke Lavi, Robert Tjian, Xavier Darzacq","General Catalyst, StepStone Group, Schroders Capital, Lux Capital, EcoR1 Capital"
FFF Enterprises,"FFF Enterprises is a Pharmaceuticals supplier of critical-care biopharmaceuticals, plasma products and vaccines.",United States,251-500,"$1,119,000,000",USD,debt_financing,"Biotechnology, Health Care, Medical, Pharmaceutical",FFF Enterprises,Patrick M. Schmidt,
Travere Therapeutics,Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.,United States,101-250,"$1,067,000,000",USD,post_ipo_equity,"Biotechnology, Health Care, Medical",Travere Therapeutics,Martin Shkreli,Athyrium Capital Management LP
Arena Pharmaceuticals,"Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.",United States,251-500,"$1,059,760,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical",Arena Pharmaceuticals,Dominic Behan,"Deerfield, Farallon Capital Management, Deerfield Capital Management"
Structure Therapeutics,Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.,United States,101-250,"$1,054,400,640",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Pharmaceutical, Product Research",Structure Therapeutics,Raymond Stevens,"Qiming Venture Partners, HSG, Cormorant Asset Management, Lilly Asia Ventures, Janus Henderson Investors"
Kodiak Sciences,Kodiak is designing and developing novel therapies for the treatment of retinal disease.,United States,101-250,"$1,031,230,000",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics",Kodiak Sciences,"Stephen Charles, Victor Perlroth","Perceptive Advisors, ArrowMark Partners, Rivas Capital"
Aerie Pharmaceuticals,Aerie Pharmaceuticals is a clinical-stage pharmaceutical company developing products for the treatment of glaucoma.,United States,251-500,"$1,026,114,965",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Pharmaceutical",Aerie Pharmaceuticals,"Casey C. Kopczynski, Thomas J. van Haarlem","Sofinnova Investments, OUP (Osage University Partners), Deerfield, Alta Partners, TPG Biotech"
Click Therapeutics,Click Therapeutics develops software as a medical treatment prescription platform designed to deliver digital treatments for patients.,United States,101-250,"$1,006,229,459",USD,series_c,"Biotechnology, Health Care, Medical Device, Pharmaceutical, Therapeutics",Click Therapeutics,"Bruce Leuchter, David Benshoof Klein, Victor Gao","Accelmed, Hikma Ventures, Revelation Partners, Boehringer Ingelheim, Silicon Valley Bank"
Assertio,Assertio is a pharmaceutical company focused on developing and commercializing products to treat pain and other.,United States,101-250,"$1,006,000,000",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics, Life Science, Medical, Pharmaceutical",Assertio,,"Morgan Stanley, Deerfield, RBC Capital Markets, Pharmakon Advisors, Thomas Weisel Partners"
Xaira Therapeutics,Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.,United States,51-100,"$1,000,000,000",USD,series_a,"Artificial Intelligence (AI), Biotechnology, Health Care, Therapeutics",Xaira Therapeutics,"Arvind Rajpal, David Baker, Don Kirkpatrick, Hetu Kamisetty, Joe Watchwell Watson, Marc Tessier-Lavigne","Menlo Ventures, New Enterprise Associates, Sequoia Capital, Lightspeed Venture Partners, Lux Capital"
Biomat USA,Biomat USA is a blood and plasma donation center.,United States,251-500,"$1,000,000,000",USD,private_equity,Health Care,Biomat USA,J.A. Grifols Roig,GIC
NantHealth,NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics.,United States,251-500,"$980,200,000",USD,post_ipo_debt,"Health Care, Health Diagnostics, Hospital, Medical, Therapeutics",NantHealth,Patrick Soon-Shiong,"Blackstone Group, Blackberry, Highbridge Capital Management, Veradigm, Kuwait Investment Authority"
Heron Therapeutics,Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.,United States,101-250,"$974,050,000",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics",Heron Therapeutics,Barry Quart,"Great Point Partners, Hercules Capital, Deep Track Capital, Rubric Capital Management, Tang Capital Management"
Vera Therapeutics,Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.,United States,101-250,"$971,400,000",USD,post_ipo_debt,"Biotechnology, Health Care",Vera Therapeutics,Marshall Fordyce,"Kleiner Perkins, Longitude Capital, Fidelity, Abingworth, Alexandria Venture Investments"
Global Blood Therapeutics,GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.,United States,251-500,"$969,500,000",USD,post_ipo_debt,"Biotechnology, Genetics, Medical, Therapeutics",Global Blood Therapeutics,"Andrej Sali, Charles Homcy, Craig Muir, David Phillips, Jack Taunton, Matthew Jacobson","Wellington Management, RA Capital Management, Third Rock Ventures, Deerfield, Sabby Capital"
Nuvation Bio,Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.,United States,101-250,"$927,000,000",USD,post_ipo_debt,"Biotechnology, Health Care, Pharmaceutical",Nuvation Bio,"David Hung, Gary Hattersley","Wellington Management, OrbiMed, Perceptive Advisors, Fidelity, Ally Bridge Group"
Vir Biotechnology,Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.,United States,251-500,"$908,600,000",USD,grant,"Biotechnology, Health Care, Medical, Therapeutics",Vir Biotechnology,"Klaus Frueh, Louis Picker, Robert Nelsen","Bill & Melinda Gates Foundation, ARCH Venture Partners, SoftBank Vision Fund, Alta Partners, GlaxoSmithKline"
Transcarent,Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.,United States,251-500,"$904,999,962",USD,undisclosed,"Health Care, Personal Health, Software",Transcarent,Glen Tullman,"General Catalyst, Kleiner Perkins, Human Capital, Geodesic Capital, Ally Bridge Group"
Rocket Pharmaceuticals,Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.,United States,251-500,"$891,357,888",USD,post_ipo_equity,"Biotechnology, Genetics, Health Care, Pharmaceutical",Rocket Pharmaceuticals,Gaurav Shah,"RTW Investments, Frazier Healthcare Partners, Civilization Ventures, California Institute for Regenerative Medicine, Sahsen Ventures"
Ligand Pharmaceuticals,Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.,United States,101-250,"$875,000,000",USD,post_ipo_debt,"Biotechnology, Medical, Pharmaceutical",Ligand Pharmaceuticals,Brook Byers,Venrock
IVERIC bio,IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.,United States,101-250,"$857,900,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical",IVERIC bio,Samir Patel,"SV Health Investors, Novo Holdings, Frazier Healthcare Partners, Sofinnova Investments, Clarus Ventures"
Gossamer Bio,Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.,United States,101-250,"$812,000,000",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics",Gossamer Bio,"Faheem Hasnain, Sheila Gujrathi","New Enterprise Associates, ARCH Venture Partners, Samsara BioCapital, Hillhouse Investment, MidCap Financial"
Puma Biotechnology,Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.,United States,101-250,"$809,300,000",USD,post_ipo_equity,"Biotechnology, Medical, Therapeutics",Puma Biotechnology,Alan H. Auerbach,"OrbiMed, Silicon Valley Bank, Adage Capital Management, T. Rowe Price, Athyrium Capital Management LP"
Immunomedics,Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer.,United States,101-250,"$802,000,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Therapeutics",Immunomedics,David M. Goldenberg,New Enterprise Associates
Biosplice Therapeutics,Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.,United States,51-100,"$778,000,000",USD,grant,"Biotechnology, Health Care, Life Science",Biosplice Therapeutics,Osman Kibar,"Sands Capital Ventures, Verition Fund Management, Vickers Venture Partners, Swicorp, aMoon Fund"
Audentes Therapeutics,Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.,United States,251-500,"$744,700,000",USD,post_ipo_equity,"Biotechnology, Genetics, Health Care, Health Diagnostics",Audentes Therapeutics,"Matthew Patterson, Thomas Schuetz","Cormorant Asset Management, RA Capital Management, OrbiMed, Versant Ventures, Venrock"
ADMA Biologics,ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.,United States,51-100,"$742,350,000",USD,post_ipo_debt,"Biotechnology, Health Care, Manufacturing, Medical",ADMA Biologics,"Adam Grossman, Jerrold B. Grossman","Ares Management, Perceptive Advisors, Marathon Asset Management, Aisling Capital, Hercules Capital"
Rakuten Medical,Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox™ platform.,United States,101-250,"$737,591,700",USD,grant,"Biotechnology, Health Care, Medical, Service Industry, Therapeutics",Rakuten Medical,Miguel Garcia Guzman,"General Catalyst, Rakuten, Dai-ichi Life, Mizuho Bank, Hikma Pharmaceuticals"
Auris Health,Auris Health engages in the development of robotics technology for medical applications.,United States,101-250,"$733,296,837",USD,secondary_market,"Biotechnology, Health Care, Medical, Medical Device, Robotics",Auris Health,"Christopher J. P. Velis, Fred Moll, M.D, Hari Sundram","Wellington Management, Coatue, Lux Capital, S32, Highland Capital Partners"
Kindly MD,"Kindly MD is a healthcare company that provides sleep support, pain treatment, and data analytics solutions for medication management.",United States,51-100,"$710,000,000",USD,post_ipo_equity,"Analytics, Health Care, Medical",Kindly MD,Timothy Pickett,"Eric Semler, Jihan Wu, VanEck, Arrington Capital, Balaji Srinivasan"
Precigen,Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.,United States,101-250,"$709,803,901",USD,post_ipo_equity,"Biotechnology, Life Science, Medical, Therapeutics",Precigen,Thomas D. Reed,"Third Security, Randal J. Kirk, Patient Capital Management, Bill Miller, NewVa Capital Partners"
IGM Biosciences,"IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.",United States,101-250,"$699,301,000",USD,post_ipo_equity,"Biotechnology, Medical, Therapeutics",IGM Biosciences,Nelson Teng,"Vivo Capital, Redmile Group, Janus Henderson Investors, Topsoe, Baker Brothers Advisors LLC"
Pliant Therapeutics,"Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.",United States,101-250,"$694,945,146",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics, Pharmaceutical, Recruiting, Therapeutics",Pliant Therapeutics,"Bill DeGrado, Bradley Backes, Dean Sheppard, Hal Chapman","Menlo Ventures, Cormorant Asset Management, Redmile Group, Third Rock Ventures, Agent Capital"
IDEAYA Biosciences,IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.,United States,101-250,"$694,100,000",USD,post_ipo_equity,"Biotechnology, Health Care, Oncology, Therapeutics",IDEAYA Biosciences,"Jeffrey Hager, Yujiro S. Hata","Perceptive Advisors, 5AM Ventures, Alexandria Venture Investments, Canaan Partners, Google Ventures"
Day One Biopharmaceuticals,Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.,United States,101-250,"$687,500,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Pharmaceutical",Day One Biopharmaceuticals,"Julie Papanek Grant, Samuel Blackman","Franklin Templeton, Wellington Management, RA Capital Management, Frazier Healthcare Partners, Perceptive Advisors"
Xencor,"Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.",United States,251-500,"$683,897,653",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics",Xencor,Bassil Dahiyat,"Novo Nordisk, Stafford Capital Partners, Moore Capital, Oxford Bioscience Partners, Sands Brothers"
RefleXion Medical,RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.,United States,251-500,"$675,100,000",USD,series_unknown,"Biotechnology, Health Care, Medical, Medical Device, Therapeutics",RefleXion Medical,"Akshay Nanduri, Sam Mazin","Venrock, Catalio Capital Management, Sofinnova Partners, Sixty Degree Capital, Ally Bridge Group"
Relypsa,Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.,United States,251-500,"$669,029,887",USD,post_ipo_debt,"Biopharma, Biotechnology, Health Care",Relypsa,Gerrit Klaerner,"OrbiMed, 5AM Ventures, Silicon Valley Bank, New Leaf Venture Partners, Athyrium Capital Management LP"
Theravance Biopharma,Theravance Biopharma is a biopharmaceutical company with one approved product.,United States,251-500,"$663,200,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical",Theravance Biopharma,George Whitesides,"Lauder Partners, Woodford Investment Management"
Apogee Therapeutics,Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.,United States,101-250,"$652,000,000",USD,post_ipo_equity,"Biotechnology, Life Science, Medical, Therapeutics",Apogee Therapeutics,Nimish Shah,"Wellington Management, RA Capital Management, Perceptive Advisors, OrbiMed, RTW Investments"
Insitro,Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.,United States,251-500,"$643,000,000",USD,series_c,"Biotechnology, Health Care, Life Science, Machine Learning, Pharmaceutical, Therapeutics",Insitro,Daphne Koller,"Andreessen Horowitz, BlackRock, Temasek Holdings, Verily, ARCH Venture Partners"
Sutro Biopharma,Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.,United States,251-500,"$636,605,000",USD,post_ipo_equity,"Biotechnology, Information Technology, Medical",Sutro Biopharma,James R. Swartz,"Eli Lilly, SV Health Investors, Frazier Healthcare Partners, Samsara BioCapital, Blackstone Life Sciences"
ChemoCentryx,ChemoCentryx is a biopharmaceutical company that develops medications for inflammatory and autoimmune diseases and cancer.,United States,101-250,"$634,340,000",USD,post_ipo_equity,"Biotechnology, Health Care, Medical Device",ChemoCentryx,Thomas J. Schall,"OrbiMed, HealthCap, Hercules Capital, Alta Partners, Jennison Associates"
Senseonics,"Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.",United States,101-250,"$634,299,998",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Medical Device, Sensor, Wearables",Senseonics,M. James Barrett,"New Enterprise Associates, Rho Capital Partners, Abingworth, Hercules Capital, Abbott"
Annexon Biosciences,"Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.",United States,101-250,"$633,999,999",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics, Life Science, Therapeutics",Annexon Biosciences,"Arnon Rosenthal, Ben Barres","New Enterprise Associates, BlackRock, Correlation Ventures, Blackstone Life Sciences, Redmile Group"
ArsenalBio,ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.,United States,251-500,"$630,806,682",USD,series_c,"Biotechnology, Cloud Computing, Life Science, Medical",ArsenalBio,"Ken Drazan, Kole Roybal, W. Nicholas Haining","Sixth Street, Kleiner Perkins, ARCH Venture Partners, Hitachi Ventures, SoftBank Vision Fund"
Impulse Dynamics,Impulse Dynamics is a medical device company offering innovative solutions for the treatment of chronic heart failure.,United States,101-250,"$627,765,181",USD,series_unknown,"Biotechnology, Hospital, Medical, Medical Device",Impulse Dynamics,"Lewis Pell, Shlomo Haim","Wellington Management, Perceptive Advisors, Redmile Group, Kennedy Lewis Investment Management, Alger"
Tricida,Tricida operates in the healthcare industry focusing on pharmaceutical business.,United States,51-100,"$624,014,244",USD,post_ipo_debt,"Health Care, Medical, Pharmaceutical",Tricida,Gerrit Klaerner,"Wellington Management, Cormorant Asset Management, OrbiMed, Venrock, Frazier Healthcare Partners"
Arcellx,Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.,United States,101-250,"$621,999,986",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical",Arcellx,David Hilbert,"New Enterprise Associates, Samsara BioCapital, SR One, Novo Holdings, Soleus Capital"
Commure,Commure is an AI-based company that specializes in health care.,United States,251-500,"$620,502,055",USD,series_unknown,"Health Care, Innovation Management, Software",Commure,"Diede van Lamoen, Eugene Kuznetsov, Hemant Taneja","General Catalyst, Quiet Capital, FJ Labs, Human Capital, Green Sands Equity"
Century Therapeutics,Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.,United States,101-250,"$620,000,000",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics",Century Therapeutics,Marcela Maus,"OrbiMed, RA Capital Management, Versant Ventures, Fidelity, Bain Capital Life Sciences"
Gritstone bio,Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.,United States,101-250,"$604,100,000",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics",Gritstone bio,Andrew Allen,"Redmile Group, Versant Ventures, Frazier Healthcare Partners, Gilead Sciences, Lilly Asia Ventures"
Kriya Therapeutics,"Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.",United States,101-250,"$600,500,000",USD,series_c,"Biotechnology, Health Care, Life Science",Kriya Therapeutics,"Fraser Wright, Roger Jeffs, Shankar Ramaswamy","Alumni Ventures, Amplo, Patient Square Capital, Narya Capital, Foresite Capital"
Ultima Genomics,Ultima Genomics is a developer of a low-cost sequencing platform.,United States,251-500,"$600,000,000",USD,series_unknown,"Biotechnology, Health Care, Life Science, Medical",Ultima Genomics,"Gilad Almogy, Mark Pratt","Andreessen Horowitz, General Atlantic, Lightspeed Venture Partners, Khosla Ventures, Founders Fund"
Immunome,"Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.",United States,101-250,"$598,854,487",USD,post_ipo_equity,"Biopharma, Biotechnology, Medical, Pharmaceutical",Immunome,Scott Dessain,"Redmile Group, EcoR1 Capital, BioAdvance, Avidity Partners, Janus Henderson Investors"
Nkarta Therapeutics,Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.,United States,101-250,"$595,000,000",USD,post_ipo_equity,"Biotechnology, Health Care",Nkarta Therapeutics,Dario Campana,"New Enterprise Associates, OrbiMed, RA Capital Management, Cormorant Asset Management, Samsara BioCapital"
Immunic Therapeutics,Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.,United States,51-100,"$594,463,541",USD,post_ipo_equity,"Biotechnology, Life Science, Medical, Therapeutics",Immunic Therapeutics,Andreas Muehler,"High-Tech Gruenderfonds, Vivo Capital, RTW Investments, Soleus Capital, Omega Funds"
Rapt Therapeutics,Rapt  is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.,United States,101-250,"$590,200,016",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics",Rapt Therapeutics,Brian Wong,"OrbiMed, Kleiner Perkins, RTW Investments, Perceptive Advisors, Redmile Group"
Olema Oncology,Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.,United States,101-250,"$575,054,922",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Medical, Oncology, Pharmaceutical",Olema Oncology,"Cyrus L. Harmon, Peter Kushner","Wellington Management, BlackRock, Lightspeed Venture Partners, Venrock, OrbiMed"
Evolus,Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.,United States,251-500,"$574,004,780",USD,post_ipo_debt,"Biotechnology, Health Care, Pharmaceutical",Evolus,,"Oxford Finance LLC, Pharmakon Advisors"
Sangamo Therapeutics,"Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.",United States,251-500,"$569,100,000",USD,post_ipo_equity,"Biotechnology, Genetics, Health Care, Pharmaceutical, Therapeutics",Sangamo Therapeutics,Edward Lanphier,"National Institutes of Health, California Institute for Regenerative Medicine"
Atara Biotherapeutics,"Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.",United States,101-250,"$566,816,156",USD,post_ipo_equity,"Biotechnology, Health Care, Oncology, Therapeutics",Atara Biotherapeutics,Isaac Ciechanover,"Kleiner Perkins, Redmile Group, EcoR1 Capital, Domain Associates, Panacea Venture"
Silk Road Medical,Silk Road Medical specializes in providing medical devices and solutions for the treatment of vascular diseases.,United States,251-500,"$560,625,793",USD,post_ipo_equity,"Health Care, Medical, Medical Device, Therapeutics",Silk Road Medical,"Michi Garrison, Tony M. Chou","Norwest Venture Partners, Warburg Pincus, CRG, Armentum Partners, Oxford Finance LLC"
Imperative Care,Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.,United States,251-500,"$558,969,993",USD,series_e,"Health Care, Medical, Medical Device",Imperative Care,Nick Hopkins,"Ally Bridge Group, Catalio Capital Management, Bain Capital Life Sciences, Rock Springs Capital, Delos Capital"
ACELYRIN,"ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.",United States,101-250,"$558,000,000",USD,series_c,"Biopharma, Biotechnology, Health Care",ACELYRIN,"Robert Carey, Shao-Lee Lin","OrbiMed, RTW Investments, Samsara BioCapital, Decheng Capital, Westlake Village BioPartners"
Ardelyx,Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.,United States,251-500,"$557,675,321",USD,post_ipo_debt,"Biotechnology, Health Care, Medical",Ardelyx,"Dominique Charmot, Peter G. Schultz","New Enterprise Associates, RA Capital Management, Cormorant Asset Management, Perceptive Advisors, EcoR1 Capital"
CG Oncology,CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.,United States,51-100,"$555,570,000",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics, Oncology",CG Oncology,Paul DeRidder,"RA Capital Management, Longitude Capital, Ally Bridge Group, Avidity Partners, Janus Henderson Investors"
Xeris Biopharma,"Xeris Biopharma is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.",United States,251-500,"$548,500,000",USD,post_ipo_debt,"Biotechnology, Diabetes, Health Care, Pharmaceutical, Therapeutics",Xeris Biopharma,"John Kinzell, Steven Prestrelski","Mérieux Equity Partners, Deerfield, Redmile Group, Silicon Valley Bank, Hayfin Capital Management"
Krystal Biotech,Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..,United States,251-500,"$546,000,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care",Krystal Biotech,Suma Krishnan,"Redmile Group, Frazier Healthcare Partners, Frazier Life Sciences, Avoro Capital Advisors, Sun Pharmaceutical Industries"
Nurix Therapeutics,Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.,United States,251-500,"$545,900,000",USD,post_ipo_equity,"Biotechnology, Health Care, Life Science, Therapeutics",Nurix Therapeutics,"Arthur Weiss, John Kuriyan, Michael Rape","Wellington Management, Bain Capital Life Sciences, Foresite Capital, Third Rock Ventures, EcoR1 Capital"
NGM Biopharmaceuticals,NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.,United States,101-250,"$542,438,996",USD,series_a,"Biopharma, Biotechnology, Genetics, Medical",NGM Biopharmaceuticals,Jin-Long Chen,"Merck, The Column Group, Rho Capital Partners, Topspin Partners, Greenspring Associates"
ORIC Pharmaceuticals,ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.,United States,51-100,"$533,000,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics",ORIC Pharmaceuticals,"Charles Sawyers, Richard Heyman, Scott Lowe","New Enterprise Associates, Point72, OrbiMed, Vivo Capital, Pfizer"
Dice Therapeutics,Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.,United States,51-100,"$532,381,896",USD,post_ipo_equity,"Biotechnology, Medical, Medical Device",Dice Therapeutics,"Kevin Judice, Phil Patten","RA Capital Management, Sands Capital Ventures, Soleus Capital, Agent Capital, OUP (Osage University Partners)"
Formation Bio,Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.,United States,101-250,"$528,000,000",USD,series_d,"Artificial Intelligence (AI), Biotechnology, Clinical Trials, Health Care, Medical, Pharmaceutical",Formation Bio,"Benjamine Liu, Kit Dobyns, Linhao Zhang","Andreessen Horowitz, Sequoia Capital, FPV Ventures, Sanofi, Thrive Capital"
Viela Bio,Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.,United States,101-250,"$526,253,240",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Diagnostics, Medical, Wellness",Viela Bio,,"Temasek Holdings, Cormorant Asset Management, Goldman Sachs, AstraZeneca, Hillhouse Investment"
Exelixis,"Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.",United States,251-500,"$514,000,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical",Exelixis,"Corey Goodman, Stelios Papadopoulos","Deerfield, Silicon Valley Bank, Atlas Venture, Oxford Bioscience Partners, PaineWebber"
Inovio Pharmaceuticals,"Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.",United States,101-250,"$512,383,430",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Inovio Pharmaceuticals,"David Weiner, J. Joseph Kim","Bill & Melinda Gates Foundation, Korea Investment Partners, U.S. Department of Defense, DARPA, Deep Track Capital"
Prothena,Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.,United States,101-250,"$505,499,997",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics",Prothena,Dennis Selkoe,Sofinnova Investments
Metsera,Metsera is a biopharmaceutical company that develops medicines for obesity and metabolic diseases.,United States,51-100,"$505,000,000",USD,series_b,"Biopharma, Health Care, Medical, Pharmaceutical",Metsera,Whit Bernard,"Wellington Management, RA Capital Management, ARCH Venture Partners, SoftBank Vision Fund, Fidelity"
Ambrx,Ambrx is a clinical-stage biopharmaceutical company using expanded genetic code technology for next-gen therapies and immune modulation.,United States,51-100,"$500,949,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Life Science, Therapeutics",Ambrx,"Peter Schultz, Troy Wilson","BlackRock, Cormorant Asset Management, Maverick Ventures, Versant Ventures, Fidelity"
Outcome Health,Outcome Health delivers better health outcomes and impacts the human condition positively through technology.,United States,101-250,"$500,000,000",USD,private_equity,"Digital Media, Health Care, Information Technology, Life Science, Medical Device",Outcome Health,"Rishi Shah, Shradha Agarwal","Goldman Sachs, CapitalG, Prudence, BAM Elevate, 50 South Capital"
Provention Bio,"Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.",United States,101-250,"$498,500,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Provention Bio,"Ashleigh Palmer, Francisco Leon","Sanofi, Hercules Capital, MDB Capital Group, JDRF T1D Fund, Armistice Capital"
Terns Pharmaceuticals,Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.,United States,51-100,"$498,450,000",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical",Terns Pharmaceuticals,Weidong Zhong,"OrbiMed, Eli Lilly, Vivo Capital, Lilly Asia Ventures, Deerfield"
Otonomy,Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.,United States,51-100,"$498,012,625",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care",Otonomy,"Allen F. Ryan, Jay Lichter, Jeffrey Harris","OrbiMed, Perceptive Advisors, Ally Bridge Group, OUP (Osage University Partners), RiverVest"
Mirum Pharmaceuticals,Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.,United States,251-500,"$497,000,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Mirum Pharmaceuticals,"Alejandro Dorenbaum, Christopher Peetz, Niall O'Donnell, Susan Dubé","New Enterprise Associates, Novo Holdings, Frazier Healthcare Partners, Oberland Capital, Pappas Capital"
Sierra Oncology,Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.,United States,101-250,"$494,131,452",USD,post_ipo_equity,"Biotechnology, Health Care, Life Science, Oncology, Therapeutics",Sierra Oncology,"Mina Patel Sooch, Robert Forgey","RA Capital Management, OrbiMed, Frazier Healthcare Partners, Vivo Capital, Capital Midwest Fund"
Lyell Immunopharma,Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.,United States,251-500,"$492,999,957",USD,series_c,"Biotechnology, Health Care, Medical, Pharmaceutical",Lyell Immunopharma,"Rick Klausner, Scott Boyken","Bill & Melinda Gates Foundation, ARCH Venture Partners, Mubadala, Arrive, Sahsen Ventures"
Proteus Digital Health,"Proteus Digital Health develops digital medicines that collect and aggregate various behavioral, physiological and therapeutic metrics.",United States,251-500,"$491,975,979",USD,series_unknown,"Health Care, Medical, Mobile, Pharmaceutical",Proteus Digital Health,"Andrew Thompson, George Savage, Mark Zdeblick","Adams Street Partners, Novartis, The Carlyle Group, Oracle, Asset Management Ventures (AMV)"
Arcturus Therapeutics,Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.,United States,101-250,"$489,580,050",USD,grant,"Biotechnology, Genetics, Health Care, Medical, Therapeutics",Arcturus Therapeutics,"Joseph Payne, Pad (Padmanabh) Chivukula","Cystic Fibrosis Foundation, Biomedical Advanced Research and Development Authority (BARDA), Japan - The Government of Japan"
Kallyope,Kallyope uses the science of gut-brain biology to create medicines that transform human health.,United States,51-100,"$487,200,000",USD,grant,"Biotechnology, Health Care, Medical, Pharmaceutical",Kallyope,"Charles Zuker, Richard Axel, Tom Maniatis","StepStone Group, Bill & Melinda Gates Foundation, Lux Capital, Two Sigma Ventures, Polaris Partners"
Adamas Pharmaceuticals,Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.,United States,51-100,"$483,200,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Adamas Pharmaceuticals,Greg Went,"Northgate Capital, Mohr Davidow Ventures, DAG Ventures, Aeris Capital"
Color,"Color is a healthcare delivery platform that offers cancer prevention, screening programs, and healthcare services for people.",United States,251-500,"$482,000,000",USD,series_e,"Apps, Biotechnology, Electronic Health Record (EHR), Genetics, Health Care, Personal Health",Color,"Elad Gil, Nish Bhat, Othman Laraki, Taylor Sittler","General Catalyst, Khosla Ventures, 8VC, Caffeinated Capital, Shasta Ventures"
Regulus Therapeutics,Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.,United States,51-100,"$480,899,992",USD,post_ipo_equity,"Biotechnology, Genetics, Health Care, Therapeutics",Regulus Therapeutics,,"New Enterprise Associates, RA Capital Management, Vivo Capital, Adage Capital Management, Octagon Capital Advisors"
DNAnexus,DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery.,United States,101-250,"$472,550,000",USD,series_h,"Bioinformatics, Biotechnology, Cloud Computing, Medical, Software",DNAnexus,"Andreas Sundquist, Arend Sidow, Serafim Batzoglou","Uncork Capital, First Round Capital, Felicis, Microsoft, Perceptive Advisors"
Pharmapacks,Pharmapacks is an e-commerce company that offers products for daily health and wellness needs.,United States,101-250,"$472,500,000",USD,private_equity,"Beauty, E-Commerce, Health Care, Retail, Wellness",Pharmapacks,"Adam Berkowitz, Andrew Vagenas, Bradley Tramunti, Jonathan Webb","JP Morgan Chase, The Carlyle Group, Sealed Air, Reckitt, McKesson Ventures"
PayZen,"PayZen is a healthcare fintech startup tackling healthcare affordability by using financial technology, AI, and machine learning.",United States,51-100,"$472,000,000",USD,debt_financing,"Financial Services, FinTech, Health Care, Payments, Software",PayZen,"Ariel Rosenthal, Itzik Cohen, Tobias Mezger","New Enterprise Associates, SignalFire, Viola Ventures, Viola Credit, Picus Capital"
Evofem Biosciences,Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.,United States,51-100,"$471,800,000",USD,post_ipo_equity,"Biopharma, Health Care, Medical, Women's",Evofem Biosciences,Saundra Pelletier,"Morgan Stanley, Invesco, Domain Associates, Alta Partners, Keystone Capital"
Achillion Pharmaceuticals,A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.,United States,51-100,"$468,710,201",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",Achillion Pharmaceuticals,William Rice,"Advent International, Connecticut Innovations, Atlas Venture, Domain Associates, Clarus Ventures"
Inscripta,Inscripta is a life science technology company that develops digital genome engineering solutions.,United States,51-100,"$463,899,973",USD,series_unknown,"Biotechnology, Health Care, Life Science, Software",Inscripta,"Andrew Garst, Ryan T. Gill, Tanya Warnecke","Oak HC/FT, Venrock, Mérieux Equity Partners, Foresite Capital, Fidelity"
Abridge,Abridge is an AI-driven platform that transforms patient-clinician conversations into structured clinical notes for healthcare industries.,United States,101-250,"$457,500,000",USD,series_d,"Artificial Intelligence (AI), Electronic Health Record (EHR), Enterprise Software, Generative AI, Health Care, Intelligent Systems, Machine Learning, Medical, Natural Language Processing, SaaS",Abridge,"Florian Metze, Sandeep Konam, Shivdev Rao","Bessemer Venture Partners, Lightspeed Venture Partners, Union Square Ventures, Spark Capital, Pillar VC"
NeuroPace,NeuroPace develops and markets implantable devices for the treatment of neurological disorders.,United States,101-250,"$457,100,000",USD,post_ipo_debt,"Health Care, Manufacturing, Medical Device, Neuroscience",NeuroPace,David Fischell,"New Enterprise Associates, OrbiMed, Kleiner Perkins, MidCap Financial, National Institutes of Health"
TG Therapeutics,"TG Therapeutics, a biopharmaceutical company, develops agents for the treatment of hematologic malignancies and autoimmune disorders.",United States,251-500,"$455,000,000",USD,post_ipo_debt,"Biotechnology, Health Care, Therapeutics",TG Therapeutics,Michael S. Weiss,"Blue Owl, Hercules Capital, HealthCare Royalty Partners"
Mineralys Therapeutics,Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.,United States,51-100,"$453,000,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Medical, Pharmaceutical",Mineralys Therapeutics,BT Slingsby,"RA Capital Management, OrbiMed, Adams Street Partners, RTW Investments, Samsara BioCapital"
Ignyta,Ignyta is a biotechnology company catalyzing personalized medicine in autoimmune diseases.,United States,101-250,"$450,500,000",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics, Precision Medicine",Ignyta,"Gary Firestein, Jonathan Lim","Frazier Healthcare Partners, Silicon Valley Bank, Casdin Capital, Teva Pharmaceuticals, Oxford Finance LLC"
MindMed,MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.,United States,101-250,"$448,819,263",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",MindMed,Robert Barrow,"CIBC, Soleus Capital, Ally Bridge Group, Janus Henderson Investors, Great Point Partners"
Anacor Pharmaceutical,Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.,United States,51-100,"$448,350,000",USD,post_ipo_debt,"Biotechnology, Health Care, Pharmaceutical",Anacor Pharmaceutical,"Lucy Shapiro, Stephen Benkovic","Venrock, Rho Capital Partners, Hercules Capital, U.S. Department of the Treasury, Aberdare Ventures"
CytomX Therapeutics,CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.,United States,101-250,"$445,423,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical, Therapeutics",CytomX Therapeutics,"Fred Gluck, Nancy E. Stagliano, Patrick Daugherty","Wellington Management, Cormorant Asset Management, Venrock, OrbiMed, Perceptive Advisors"
TigerConnect,TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.,United States,251-500,"$433,900,000",USD,private_equity,"Collaboration, Compliance, Enterprise, Enterprise Software, Health Care, Information Technology, mHealth, Productivity Tools, SaaS, Software",TigerConnect,"Andrew Brooks M.D., Brad Brooks","Norwest Venture Partners, Vista Equity Partners, OrbiMed, Industry Ventures, HealthQuest Capital"
Tenaya Therapeutics,Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.,United States,101-250,"$433,500,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Therapeutics",Tenaya Therapeutics,"Benoit Bruneau, Bruce Conklin, Deepak Srivastava, Eric Olson, Saptarsi Haldar, Sheng Ding","RA Capital Management, RTW Investments, Soleus Capital, Fidelity, Google Ventures"
Abeona Therapeutics,Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.,United States,101-250,"$429,700,000",USD,post_ipo_equity,"Biotechnology, Genetics, Health Care, Manufacturing, Medical Device",Abeona Therapeutics,"Douglas McCarty, Haiyan Fu","Vivo Capital, EcoR1 Capital, Deerfield, Janus Henderson Investors, RBC Capital Markets"
Neurona Therapeutics,"Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.",United States,101-250,"$426,113,942",USD,series_f,"Biotechnology, Health Care, Therapeutics",Neurona Therapeutics,"Arnold Kriegstein, Cory R. Nicholas","Schroders Capital, Cormorant Asset Management, National Institutes of Health, Ysios Capital, Soleus Capital"
Quotient Biodiagnostics,Quotient Biodiagnostics develops and manufactures products for use in transfusion diagnostics.,United States,251-500,"$423,700,000",USD,post_ipo_equity,"Biotechnology, Health Care, Health Diagnostics, Manufacturing",Quotient Biodiagnostics,Paul Cowan,"MidCap Financial, Highbridge Capital Management, Galen Partners, Paul Cowan"
Cedar,"Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevates the patient experience.",United States,251-500,"$419,361,000",USD,series_d,"Billing, FinTech, Health Care, Medical, Payments",Cedar,"Arel Lidow, Florian Otto, Kareem Zaki","Andreessen Horowitz, Founders Fund, Thrive Capital, Craft Ventures, JP Morgan Chase"
K Health,K Health is a data-driven digital primary care system that uses AI to deliver personalized primary care services.,United States,251-500,"$418,701,397",USD,series_unknown,"Artificial Intelligence (AI), Health Care, Information Technology, mHealth, Mobile Apps, Primary and Urgent Care",K Health,"Adam Singolda, Allon Bloch, Israel Roth, Ran Shaul","BoxGroup, Primary Venture Partners, Bessemer Venture Partners, Valor Equity Partners, Max Ventures"
RayzeBio,RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.,United States,51-100,"$418,000,000",USD,series_d,"Biotechnology, Health Care, Medical Device, Pharmaceutical",RayzeBio,"Aron Knickerbocker, Deborah Charych","Cormorant Asset Management, Wellington Management, OrbiMed, Perceptive Advisors, Versant Ventures"
Presence,"Presence makes live, online special education related services available to K-12 students.",United States,251-500,"$414,156,092",USD,private_equity,"Education, Health Care, Special Education, Therapeutics, Video Conferencing",Presence,"Clay Whitehead, Jack Lynch","Ulu Ventures, New Markets Venture Partners, Bain Capital Double Impact Fund, Allen & Company, Birchmere Ventures"
Talkspace,"Talkspace is a digital therapy company that offers online therapy, online counseling, psychiatry and medication management, and self-care.",United States,251-500,"$413,700,000",USD,post_ipo_equity,"Consulting, Health Care, InsurTech, Mental Health, mHealth, Therapeutics",Talkspace,"Farid Chaouki, Oren Frank, Roni Frank","Norwest Venture Partners, Spark Capital, Deerfield, SoftBank, Qumra Capital"
TriVascular,TriVascular develops new medical devices providing optimal solutions for endovascular aortic repair (EVAR).,United States,251-500,"$412,950,270",USD,post_ipo_debt,"Health Care, Health Diagnostics, Medical Device",TriVascular,"Joseph Humphrey, Michael V. Chobotov, Robert Whirley","New Enterprise Associates, Redmile Group, Deerfield, MPM Capital, CRG"
Synergy Pharmaceuticals,Synergy Pharmaceuticals is a biopharmaceutical company developing novel therapies for the treatment of gastrointestinal conditions.,United States,101-250,"$407,231,243",USD,post_ipo_debt,"Biotechnology, Health Care, Health Diagnostics, Pharmaceutical",Synergy Pharmaceuticals,"Gary S. Jacob, Kunwar Shailubhai",CRG
Oak Street Health,Oak Street Health is a network of primary care centers for adults on Medicare.,United States,101-250,"$405,335,000",USD,post_ipo_debt,"Health Care, Health Diagnostics, Hospital, Medical, Primary and Urgent Care",Oak Street Health,"Geoff Price, Griffin Myers, Mike Pykosz","General Atlantic, Silicon Valley Bank, Hercules Capital, Oxeon Partners, Quantum Strategic Partners"
Helix,Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.,United States,101-250,"$403,000,000",USD,series_c,"Big Data, Bioinformatics, Biotechnology, Blockchain, Cryptocurrency, FinTech, Genetics, Health Care, Personal Health",Helix,"James Lu, Justin Kao, Scott Burke","Temasek Holdings, DFJ Growth, Kleiner Perkins, Warburg Pincus, Mayo Clinic"
Gynesonics,"Gynesonics develops transcervical, uterus-preserving, incision-less technologies for diagnostic and therapeutic applications.",United States,101-250,"$401,780,644",USD,series_unknown,"Health Care, Medical, Medical Device, Women's",Gynesonics,Jessica Grossman,"Bain Capital, Correlation Ventures, Runway Growth Capital, Abingworth, MVM Life Science Partners"
Sientra,Sientra is a medical device company that offers breast implant treatments for breast augmentation and reconstruction.,United States,101-250,"$400,700,000",USD,post_ipo_equity,"Health Care, Manufacturing, Medical Device, Pharmaceutical, Women's",Sientra,Hani Zeini,"OrbiMed, Goldman Sachs, Abingworth, Deerfield, Silicon Valley Bank"
Celularity,Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.,United States,101-250,"$400,000,011",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics, Wellness",Celularity,"Andrew L. Pecora, Peter Diamandis, Robert J. Hariri","Alumni Ventures, S32, Human Longevity, Heritage Group, Green D Ventures"
Neuronetics,Neuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.,United States,101-250,"$391,400,000",USD,post_ipo_equity,"Biotechnology, Health Care, Manufacturing, Medical Device, Therapeutics",Neuronetics,"Charles Epstein, Norman Weldon, Thomas D. Weldon","Industry Ventures, Polaris Partners, New Leaf Venture Partners, SLR Capital Partners, Ascension Ventures"
Orexigen Therapeutics,Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity.,United States,101-250,"$387,900,000",USD,post_ipo_equity,"Biotechnology, Health Care, Pharmaceutical",Orexigen Therapeutics,Eckard Weber,"New Enterprise Associates, Kleiner Perkins, Scale Venture Partners, MPM Capital, Sofinnova Investments"
Visby Medical,Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases.,United States,101-250,"$380,811,564",USD,grant,"Health Care, Health Diagnostics, Medical",Visby Medical,Adam de la Zerda,"Plug and Play, Lightrock, Pitango VC, J-Ventures, Cedars Sinai"
EndoGastric Solutions,EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.,United States,51-100,"$380,194,629",USD,series_unknown,"Health Care, Health Diagnostics, Medical Device",EndoGastric Solutions,"Jim Fitzsimmons, Scott J. Wolf, Stefan Kraemer","Canaan Partners, MPM Capital, CRG, Accelmed, Vertex Growth Fund"
Passage Bio,Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.,United States,51-100,"$379,500,000",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics, Wellness",Passage Bio,James Wilson,"OrbiMed, Versant Ventures, Frazier Healthcare Partners, Vivo Capital, Lilly Asia Ventures"
Crescent Biopharma,Crescent Biopharma is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.,United States,51-100,"$373,379,412",USD,post_ipo_equity,"Biotechnology, Health Care, Therapeutics",Crescent Biopharma,"John Magnani, Rachel King","New Enterprise Associates, Novartis Venture Fund, PTV Healthcare Capital, Sanofi Ventures, Alliance Technology Ventures"
Vividion Therapeutics,Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.,United States,251-500,"$371,504,616",USD,series_c,"Biotechnology, Health Care, Therapeutics",Vividion Therapeutics,"Benjamin Cravatt, Jin-Quan Yu, Phil Baran","RA Capital Management, ARCH Venture Partners, Versant Ventures, SoftBank Vision Fund, Nextech Invest"
Eargo,Eargo specializes in the design and development of hearing aids.,United States,251-500,"$371,476,928",USD,post_ipo_equity,"Health Care, Medical Device, Wearables",Eargo,"Daniel Shen, Florent Michel, Raphael Michel","New Enterprise Associates, Longitude Capital, Crosslink Capital, Maveron, Patient Square Capital"
Human Longevity,"Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.",United States,51-100,"$369,800,000",USD,series_b,"Biotechnology, Genetics, Health Care, Health Diagnostics",Human Longevity,"Elizabeth Hunker, J. Craig Venter, Peter Diamandis, Robert J. Hariri","Amino Capital, Illumina, Illumina Ventures, Threshold, Viridos"
Soleno Therapeutics,Soleno Therapeutics is a clinical-stage biopharmaceutical company.,United States,101-250,"$369,200,000",USD,post_ipo_debt,"Biotechnology, Medical, Pharmaceutical",Soleno Therapeutics,Anish Bhatnagar,"Perceptive Advisors, Abingworth, Frazier Life Sciences, Adage Capital Management, Commodore Capital"
Exagen,"Exagen is a patient focused, discovery-driven life science company serving patients affected by autoimmune rheumatic diseases.",United States,101-250,"$367,828,116",USD,post_ipo_equity,"Biotechnology, Genetics, Health Care, Health Diagnostics, Life Science, Medical, Therapeutics",Exagen,"Cole Harris, Giorgio Casaburi, Waneta Tuttle","Perceptive Advisors, Cottonwood Technology Fund, EPIC Ventures, CRG, Sun Mountain Capital"
Earlens,Earlens is a medical technology company transforming the hearing experience with the only direct sound delivery system.,United States,101-250,"$366,902,184",USD,series_unknown,"Health Care, Medical, Medical Device",Earlens,"John Winstead, Jonathan Fay, Rodney Perkins, Sunil Puria","New Enterprise Associates, Vertex Ventures, Lightstone Ventures, Vertex Ventures HC, Medtronic"
Kythera Biopharmaceuticals,"Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.",United States,101-250,"$366,900,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care",Kythera Biopharmaceuticals,"Jay Birnbaum, Nathaniel David","Versant Ventures, ARCH Venture Partners, Latham & Watkins, Invus, Wilson Sonsini Goodrich & Rosati"
Intuity Medical,Intuity Medical develops blood glucose monitoring systems for diabetes management.,United States,51-100,"$365,169,154",USD,debt_financing,"Biotechnology, Diabetes, Health Care, Medical, Medical Device",Intuity Medical,Syrous Parsay,"Versant Ventures, Venrock, U.S. Venture Partners, Silicon Valley Bank, Hercules Capital"
Bionano Genomics,Bionano Genomics is a biotechnology company that provides genome analysis solutions to researchers and clinicians.,United States,101-250,"$359,133,200",USD,post_ipo_equity,"Biotechnology, Genetics, Health Diagnostics, Medical",Bionano Genomics,Han Cao,"Legend Capital, Ben Franklin Technology Partners of Southeastern Pennsylvania, Domain Associates, LC Ventures, Novartis Venture Fund"
SetPoint Medical,SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.,United States,51-100,"$356,400,000",USD,series_unknown,"Biotechnology, Health Care, Medical, Therapeutics",SetPoint Medical,"Jim Broderick, Kevin Tracey, Shaw Warren","Norwest Venture Partners, New Enterprise Associates, Catalio Capital Management, Boston Scientific, Medtronic"
Cellares,Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.,United States,101-250,"$355,000,000",USD,series_c,"Biotechnology, Life Science, Manufacturing, Medical, Therapeutics",Cellares,"Alex Pesch, Fabian Gerlinghaus, Omar Kurdi","8VC, Eclipse Ventures, DFJ Growth, EcoR1 Capital, Bristol-Myers Squibb"
Valeritas,"Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.",United States,51-100,"$355,000,000",USD,series_unknown,"Biotechnology, Diabetes, Health Care, Medical Device",Valeritas,Robert R. Gonnelli,"U.S. Venture Partners, Pitango VC, Welsh Carson Anderson & Stowe, Abingworth, MPM Capital"
Karius,"Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.",United States,101-250,"$354,000,000",USD,series_c,"Biotechnology, Genetics, Health Care, Information Technology, Life Science, Precision Medicine",Karius,"Mickey Kertesz, Steve Quake, Tim Blauwkamp","General Catalyst, Khosla Ventures, Lightspeed Venture Partners, Seventure Partners, Tencent"
Beta Bionics,Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.,United States,251-500,"$353,452,916",USD,series_e,"Biotechnology, Diabetes, Medical Device",Beta Bionics,"Ed Damiano, Sean Saint, Toby Milgrome","Wellington Management, Eli Lilly, Sands Capital Ventures, Novo Nordisk, RTW Investments"
Pionyr Immunotherapeutics,Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.,United States,51-100,"$351,999,999",USD,corporate_round,"Biotechnology, Medical, Pharmaceutical, Therapeutics",Pionyr Immunotherapeutics,"Max Krummel, Sachdev Sidhu","New Enterprise Associates, OrbiMed, SV Health Investors, Gilead Sciences, Mission BioCapital"
RxSight,RxSight is a medical device company that offers an intraocular lens and cataract surgery solutions.,United States,251-500,"$350,975,917",USD,post_ipo_equity,"Biotechnology, Eyewear, Health Care, Medical Device",RxSight,Robert Grubbs,"RA Capital Management, Longitude Capital, Balance Point Capital Partners, Visionary Venture Fund, Oxford Finance LLC"
Center for Breakthrough Medicines,Center for Breakthrough Medicines is an innovative cell and gene therapy focusing on contract development and manufacturing organization.,United States,101-250,"$350,000,000",USD,corporate_round,"Biotechnology, Genetics, Manufacturing, Medical",Center for Breakthrough Medicines,Audrey Greenberg,SK Holdings
Aralez Pharmaceuticals,Aralez Pharmaceuticals is a global specialty pharmaceutical company.,United States,101-250,"$350,000,000",USD,post_ipo_equity,"Alternative Medicine, Biotechnology, Health Care, Medical",Aralez Pharmaceuticals,,"Deerfield, Novelion Therapeutics, Broadfin Capital, JW Asset Management"
Atreca,"Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.",United States,51-100,"$347,860,000",USD,post_ipo_equity,"Biotechnology, Health Care, Product Research, Therapeutics",Atreca,"Daniel Emerling, Guy Cavet, Jonathan Woo, Paulette Dillon, Tito A Serafini, Wayne Volkmuth, Yann Chong Tan","Wellington Management, Bill & Melinda Gates Foundation, Cormorant Asset Management, Samsara BioCapital, Redmile Group"
Five Prime Therapeutics,FivePrime is a clinical-stage biotechnology company that develops treatments for cancers.,United States,101-250,"$345,040,487",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Therapeutics",Five Prime Therapeutics,Lewis (Rusty) Williams,"TPG, Kleiner Perkins, Versant Ventures, Wellcome Trust, HealthCap"
Acutus Medical,Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.,United States,51-100,"$343,176,464",USD,post_ipo_debt,"Biotechnology, Health Care, Health Diagnostics, Manufacturing, Medical Device",Acutus Medical,Randy Werneth,"8VC, Index Ventures, OrbiMed, Deerfield, Deerfield Capital Management"
Athenex,Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.,United States,251-500,"$342,149,580",USD,post_ipo_equity,"Biotechnology, Medical, Pharmaceutical",Athenex,"Allen Barnett, David Hangauer","OrbiMed, Perceptive Advisors, Kingdon Capital, Mandra Capital"
JenaValve Technology,JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions,United States,101-250,"$341,567,865",USD,series_c,"Health Care, Manufacturing, Medical Device",JenaValve Technology,"Hans-Reiner Figulla, Ronald Reich","Cormorant Asset Management, Bain Capital Life Sciences, Legend Capital, VI Partners, Omega Funds"
Capstan Therapeutics,Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.,United States,101-250,"$340,000,000",USD,series_b,"Biotechnology, Health Care, Therapeutics",Capstan Therapeutics,Haig Aghajanian,"OrbiMed, RA Capital Management, Perceptive Advisors, Polaris Partners, Vida Ventures"
Sonendo,Sonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy.,United States,101-250,"$339,749,879",USD,post_ipo_equity,"Biotechnology, Health Care, Medical",Sonendo,Olav Bergheim,"General Atlantic, OrbiMed, Perceptive Advisors, Meritech Capital Partners, Redmile Group"
Y-mAbs Therapeutics,YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.,United States,51-100,"$338,800,000",USD,post_ipo_equity,"Biotechnology, Health Care, Medical, Therapeutics",Y-mAbs Therapeutics,Thomas Gad,"Sofinnova Investments, HBM Healthcare Investments, Scopia Capital"
Berkeley Lights,Berkeley Lights is a provider of research and development services using micro-droplet technology that change the biological processes.,United States,101-250,"$337,567,756",USD,debt_financing,"Biopharma, Biotechnology, Genetics, Health Care, Therapeutics",Berkeley Lights,"Bill Davidow, Igor Khandros, Ming C. Wu","Sequoia Capital, Cota Capital, Celesta Capital, Shangbay Capital, Nikon"
CardioDx,CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.,United States,51-100,"$337,261,831",USD,series_unknown,"Biotechnology, Genetics, Health Care, Health Diagnostics, Pharmaceutical",CardioDx,David Levison,"TPG, Temasek Holdings, TPG Growth, JP Morgan Chase, Kleiner Perkins"
Exo,Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.,United States,101-250,"$337,032,137",USD,debt_financing,"Health Care, Medical, Medical Device",Exo,"Janusz Bryzek, John Kokulis, Sandeep Akkaraju, Yusuf Haque","BlackRock, RA Capital Management, Sands Capital Ventures, TDK Ventures, Creative Ventures"
BioAtla,"BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.",United States,51-100,"$335,700,001",USD,post_ipo_equity,"Biotechnology, Health Care, Medical",BioAtla,"Carolyn Short, Jay M. Short","Cormorant Asset Management, Vivo Capital, EcoR1 Capital, Soleus Capital, Deerfield"
Biora Therapeutics,Biora Therapeutics is the biotech company.,United States,51-100,"$333,250,000",USD,post_ipo_equity,"Biotechnology, Health Care, Medical",Biora Therapeutics,"Harry Stylli, Paul W. Hawran","Employee Stock Option Fund, Athyrium Capital Management LP, Savitr Capital"
Avinger,Avinger is a medical device company engaged in developing catheter-based technologies and devices for treating vascular diseases.,United States,51-100,"$333,065,180",USD,post_ipo_equity,"Health Care, Manufacturing, Medical, Medical Device",Avinger,JD Simpson,"CRG, Zylox, Lucas Venture Group, Black Diamond Ventures"
P3 Health Partners,"P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.",United States,251-500,"$332,200,000",USD,post_ipo_equity,"Finance, Financial Services, Health Care, Hospital, Medical Device, Venture Capital",P3 Health Partners,Sherif Abdou,"Fidelity, Janus Henderson Investors, Chicago Pacific Founders, Leavitt Partners"
Delfi Diagnostics,"Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.",United States,101-250,"$330,500,000",USD,series_b,"Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics, Medical",Delfi Diagnostics,"Alessandro Leal, Victor Velculescu","Menlo Ventures, Point72, Eli Lilly, OrbiMed, DFJ Growth"
Sidecar Health,"Sidecar Health's employer plans empower members with transparency, control, and financial incentives to make smart healthcare decisions.",United States,251-500,"$328,000,000",USD,series_d,"FinTech, Health Care, Health Insurance, Insurance, InsurTech",Sidecar Health,"Patrick Quigley, Veronica Osetinsky","Menlo Ventures, Bond, Cathay Innovation, Tiger Global Management, GreatPoint Ventures"
Clarify Health Solutions,Clarify Health Solutions develops an intelligence platform that delivers insights across healthcare.,United States,101-250,"$327,998,000",USD,series_d,"Analytics, Artificial Intelligence (AI), Health Care, Management Information Systems, Medical",Clarify Health Solutions,"Jean Drouin, Todd Gottula","Insight Partners, BlackRock, Spark Capital, SoftBank Vision Fund, Concord Health Partners"
Forward,Forward is a healthcare startup that provides a membership-based health care system.,United States,101-250,"$325,000,000",USD,series_e,"Artificial Intelligence (AI), Health Care, Health Diagnostics, Personal Health, Subscription Service",Forward,"Adrian Aoun, Erik Frey, Ilya Abyzov, Robert Sebastian","Khosla Ventures, Founders Fund, Samsung NEXT, First Round Capital, Tencent"
PhaseBio Pharmaceuticals,"PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.",United States,51-100,"$324,300,000",USD,post_ipo_equity,"Biotechnology, Medical, Medical Device, Pharmaceutical",PhaseBio Pharmaceuticals,"Ashutosh Chilkoti, Clay B. Thorp","New Enterprise Associates, AstraZeneca, Cormorant Asset Management, National Institutes of Health, Hatteras Venture Partners"
Alector,Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.,United States,101-250,"$319,500,000",USD,post_ipo_debt,"Biotechnology, Genetics, Health Care, Therapeutics",Alector,"Arnon Rosenthal, Asa Abeliovich, Errik Anderson, Tillman Gerngross","OrbiMed, AbbVie, S32, Perceptive Advisors, Polaris Partners"
"EmendoBio, Inc.",Emendo is a biotechnology company,United States,51-100,"$317,750,000",USD,corporate_round,"Biotechnology, Health Care, Pharmaceutical, Therapeutics","EmendoBio, Inc.","David Baram, Shilo Ben Zeev","OrbiMed, Takeda Ventures, AnGes"
Caribou Biosciences,Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.,United States,101-250,"$317,699,904",USD,post_ipo_equity,"Biotechnology, Health Care, Oncology, Therapeutics",Caribou Biosciences,"James Berger, Jennifer Doudna, Martin Jinek, Rachel E. Haurwitz","National Science Foundation, AbbVie, Pfizer, Novartis, Maverick Ventures"
Redesign Health,Redesign Health is a global venture builder that empowers founders to launch and scale transformative healthcare companies.,United States,101-250,"$315,000,000",USD,series_c,"Artificial Intelligence (AI), Health Care, Medical, Small and Medium Businesses, Venture Capital",Redesign Health,"Brett Shaheen, Laura Bagnoli, Leann Arkema, Susan Leonelli","General Catalyst, Samsung NEXT, Blisce, Declaration Partners, RiverPark Ventures"
Allakos,"Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.",United States,51-100,"$312,449,545",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Therapeutics",Allakos,"Christopher Bebbington, Nenad Tomasevic","New Enterprise Associates, Vivo Capital, Samsara BioCapital, Redmile Group, RTW Investments"
Personalis,Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.,United States,251-500,"$311,245,000",USD,post_ipo_equity,"Biotechnology, Genetics, Health Care, Health Diagnostics",Personalis,Atul Butte,"Tempus, Lightspeed Venture Partners, Merck, Abingworth, Stanford University"
CARGO Therapeutics,CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.,United States,101-250,"$310,000,000",USD,post_ipo_equity,"Biotechnology, Medical, Therapeutics",CARGO Therapeutics,"Crystal Mackall, Nancy Goodman, Robbie Majzner","Wellington Management, Cormorant Asset Management, Samsara BioCapital, RTW Investments, Novo Holdings"
Everest Medicines,Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.,United States,101-250,"$310,000,000",USD,series_c,"Biotechnology, Health Care, Pharmaceutical",Everest Medicines,,"RA Capital Management, Hillhouse Investment, Janus Henderson Investors, Pavilion Capital, Decheng Capital"
NextCure,NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.,United States,51-100,"$310,000,000",USD,post_ipo_equity,"Biopharma, Biotechnology, Health Care, Oncology",NextCure,Michael Richman,"OrbiMed, Eli Lilly, Pfizer, Hillhouse Investment, Lilly Asia Ventures"